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tive PCR. For these reasons we examined the question of whether changea
occur in MHC isoforms in the failing human heati, by measuring the gene
expression of a- and 5-MHC in endomyocardial biopsy specimens removed
from non-failing (NF) right ventricles (RVS) and RVS failing secondary to
primary pulmona~ hypertension (PPH) or idiopathic dilated cardiomyopa-
thy (lDC). Atrial natt’iuretic peptide (ANP) and SR calcium ATPase (SRCA)
were alao measured. mRNA abundance was quantitated by RT-PCR using
a simultaneously amplified internal standard.
RVEF % mRNA (molecules x 107/#g RNA) MHC %
ANP SRCA u-MHC @-MHC .-MHC /3-MHC
NF (n =5) 57*2 2.1+0,6 6.2+1.2 3.S+0.9 S.S+0.5 26.S+1.2 73.2+ 1.2
PPH (n = 6) 32*3* 15+4 5.3+0.5 1.0+0.2” 16*3 7.0+2.0” 93,0+2.0”
DC (n= 17) 39i4* 11+3 5.2+0.5 1.9+0.2” 17+2 9.S+1.4” 90.2+1.4”
*P< 0.05vs NF, ANOVA.
Assuming a four-fold difference in speed of contraction in favor of the
a-isoform, these changes would result in a reduction in velocity of shortening
by 33% in PPH and 28% in IDC.
Corrckrsions:Changes in MHC isoforms appear to occur in the failing hu-
man heart. These changes could be responsible for the decrease in intrinsic
systolic funclion which characterizes human myocerdial failure.
I 104O-3OI RyanodineRestituteSFrequencYPOtentiatiOnOf
ContractileForcein FaiiingHumanMyocardium
U. Schotten, C. Schumacher, T. Wiederin, M. Hense, M. Sigmund,
F.Sch6ndube W. Hugel P. Hanrath. Medical Clinic L Aachen, Germany
1Dept. of Thorecic and Cardiovascular Surge~, RWTHAachen, Germany
In patients suffering from end-stage heart failure due todilative cardiomyopa-
thy (DCM) the positive inotropic effect of increasing beating rates (positive
‘Treppe”) is abolished. Altered calcium handling by the sarcoplasmic retic-
ulum (SR) is supposed to be of major pethophysiological relevance. The
plant alkaloid ryanodine binds to the SR calcium release channel. It inhibits
the repetitive opening and cloaing of the channel, reaulting in a functional
blockade of the periodical storage and release of calcium by the SR. In the
present study the effects of ryanodine on force of contraction of thin left ven-
tricular strips obtained from explanted hearts with DCM were investigated.
At 0.5 Hz (3PC) ryancdine had a pronounced negative inotropic effect (lCm:
2.1 [1.6-2.8] nmolll; n =6) which waa almost maximal at 10 nmoll (force of
mntraction = 32 + 30/’ of pradrug value, p <0.001, n = 6). Whereas force-
frequency relation (FFR) was positive in a myocardial strip of a nonfailing
heart (NF) obtained from a multiorgan donor the FFR was flat in DCM (see
table). Ryanodine (10 nmo!fl, RYA) restored the positive shape of the FFR
in DCM. Table: force of contraction in YO of 0.5 Hz; DCM: IOOYO= 2.2 + 0.6
mN/mti, n =6; NF: 100% = 1.7 mN/mm2, n = 1; beating rates in Hz. *P <
0.05 vs 0.5 Hz.
Hz: 0.5 1.0 1.5 2.0 3.0
NF 100 109 133 173 178
DCM 100 103+ 4 104+ 5 103h 6 65& 7
DCM+ RYA 100 148 * 10* 172 + 19* 160 + 29’ 17S * 36*
Conclusion: The functional blockade of the SR by ryanodine results in a
reduction in human myocardial force of contraction of more than two third,
i.e. the intracellular calcium metabolism by the SR mainly contributes to
force generation. After blockade of the SR the normal positive shape of FFR
is restored in DCM. We conclude that the abnormal FFR in failing human
myocardium is mainly due to altered SR calcium handling.
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D1041 1 inhaiedNitricOxideimproveeExerciaeCapacityinPatientawithSevereHeartFaiiureandRight
VentricularDysfunction
T.M. Koelling, M. Kirmse, P.P.Pappegianopoulos, G. William Dee,T.G. Di
Salvo, R.M. Kacmarek, W.M. Zapol, M.J. Semigran. Massachusetts
General Hoapitaland Harvafd Medical School, Boston, MA, USA
compromised right ventricular function in patienta with severe hearl failure.
To assess the effects of the selective pulmonary vasodilator inhaled nitric
oxide (iNO), we studied 14 heart failure patients (age 50 + 3 years (mean +
SEM), male 79%, NYHA Class Ill 100%, CAD 43%, LVEF 0.25+ 0.02) with
bicycle ergometry (12.5 watt/rein ramp protocol) and respiratory gas analysis
at baseline and during iNO 40ppm. First-pass radionuclide ventriculography
was performed prior to the tm.eline study. Peak work load improved in 6
patients, and VOzmax and AT improved in 8 patients. Percentage changes
in work and AT with respect to baseline mean PA pressure and RVEF are
shown in the table below. Leff ventricular end-diastolic volumeindex > 125
ml/k42and PCW >16 mmHg also predicted increases in AT.with iNO. (*p <
0.05)
4AChanga withiNO PA <24 PA z 24 RVEF s 0.35 RVEF >0.35
(n=7) (n=6) (n =7) (n=7)
work(%) 7*17 9*7 23+ 14” –22 *13
AT (%) –11 *22 34* 2s” 21 +23 –18*3O
Conclusion.’ Patients with severe heart failure, elevated PA and PCW
pressure, left ventricular dilation, and impaired right ventricular function,
show an improvement in exercise capacity with inhaled nitric oxide.
11041-21 inducibieNitricOxideSyntha8eirtSkeietaiMuscie
of PatientswithChronicHaartFaiiure
U.N. Riede, U. F&stermann, H. Drexler. Medizinische /-fochschu/e
Hannove< Hannove< Germany
Advanced stages of chronic hearf failure are associated with systemic cy-
tokine activation which has been shown to stimulate the expression of an
inducible nitric oxide synthase (iNOS) in various cell types. We hypothetaized
that systemic eytokine activation should lead to the expression of iNOS in
skeletal muscle of patients with chronic heart failure. Skeletal muscle speci-
mens were obtained by percutaneous needle biopsy in 4 normal volunteers
and five patients with heart failure (NYHA class Ill). Electron microscopy
immunocytochemistry (Immunogold Iabelling) with specific NOS antibodies
showed expression iNOS in the cytosol of skeletal muacle. Reverse transcrip-
tion RNA-PCR (confirmed by competitive PCR using an internal shotiened
standard) identified iNOS mRNA in skeletal muscle and indicated that iNOS
gene expression is increased two to four fold in patients with chronic heart
failure. Conckrsiom iNOS is expressedin humanskeletalmuscle.The gene
expressionof iNOS appears to be increased in patients with severe heart
failure. Given the experimental evidence that NO attenuates the contractile
performance of skeletal muscla and can mediate muscle wasting, an in-
creased local production of nitric oxide in skeletal muscle by iNOS may have
important consequences for patients with severe heart failure.
I 1041-3] MiidHernOdynarnicirnpairrnentinPatientswith
HeartFaiiureandReducedFunctionalCapacity
M. Metra, P.Faggiano, A. D’Aloia, S. Nodari, A. Gualeni, M. Grigolato,
F. Rosselli, L. Dei Cas. Chair of Cardiology, University of fikescia, Itafy
Reduced exercise (ex) capacity may be mainly caused by skeletal muscle
reconditioning. In pts with heart failure (HF). Maximal CPX testing with
hemodynamic (hemo) monitoring was performed in 142 pts with HF and
functional limitation (peak V02 = 11.6+ 2.2 ml/k/min; range 5 to 15 mllklm;
LV EF=21 + 7%; range 9t035%). 33 pts (23%) had a mild hemo impairment
with a peak ex PWP c 20 mHg or a peak ex cardiac output >0.5 x V02 +
3 Umin. Sex, age (55 + 6 vs 58 + 9 ys), HF etiology, and psak V02 (12.0
+ 1.8 vs 11.5 k 2.3 ml/k/m) were similar between pts with mild and severe
hemo impairment.
Hemo data are summarized in the table (*p c 0.05; #p c 0.001).
Restinghemodynamics Peak ex hemodynamica
Severe Mild Severe Mild
cl 2.2 * 0.5 2.5 & 0.5” 2.5 & 0.5 5.3 & l.1#
Svl 27& S 33* 9* 26+ 7 42& S#
Swl 25& tl 34* lo# 22* 10 44* 15#
02extr (%) 35 i 10 29& 6 73* s 67+ 10#
PWP 23& 10 16+ 7~ 40* 10 34* lo#
During a follow-up of 13 + 16 months, one pt (3%) died in the group with
mild impairment of ex hemo while 34 (31%) died in the group with a severe
abnormality of ex hemo (p < 0.001). Thus, a significant propdion of pts with
functional limitation have a mild impairment of ex hemo. These pts have an
excellent prognosis and may be identified only through an hemo evaluation.
Exercise capacity may be limited by impaired pulmonary vasoreactivity and
